Publications by authors named "Michal Siegel-Kirshenbaum"
Article Synopsis
- Relapsing-remitting multiple sclerosis (RRMS) primarily affects young women, who are particularly at risk for relapses after childbirth, making effective treatment options essential.* -
- A study tracked 198 pregnant women with RRMS, comparing those treated with intravenous immunoglobulins (IVIg) to untreated controls, finding that the IVIg group had fewer relapses during and after pregnancy.* -
- Results showed a significant decrease in relapse rates and severity for the IVIg group in the post-partum period, highlighting its effectiveness in managing RRMS during this vulnerable time.*